CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 36 enrolled
Drug / intervention
12 ml total blood tubes volume +1 moreother
Likely dose
12 ml total blood tubes volumefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03396146
NCT03396146N/ACompleted
CompareCT.gov

Assay for the Pancreatic Polypeptide: an Help for Clinical Practice Guidelines in Classification of the Diabetes

Assistance Publique - Hôpitaux de Paris·interventional·Posted Jan 10, 2018·Updated Jan 15, 2026

In Brief

A clinical study evaluating 12 ml total blood tubes volume and Fecal sample for Type1diabetes. Completed, enrolled 36 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate global endocrine function within type 1 and type 3c diabetic patients, helping pancreatic polypeptide measurement.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType1diabetes
CountriesFrance
CollaboratorsCochin Hospital's Hormonology Laboratory, URC-CIC Paris Descartes Necker Cochin

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 10, 2018
Enrollment StartJun 14, 2018
Primary CompletionDec 18, 2019
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 8.5 years ago

Interventions

12 ml total blood tubes volumeother

12 ml total blood tubes at 0, +60, + 90, + 120 minutes before and after a mixed meal

Fecal sampleother

Fecal sample at inclusion